Skip to content

Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match

Effects of Intermittent Pneumatic Compression Following an Officiall Soccer Match on Elite Youth Soccer Players

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06636942
Enrollment
40
Registered
2024-10-15
Start date
2024-10-01
Completion date
2025-06-29
Last updated
2025-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Pneumatic Compression, Placebo - Control

Keywords

sports, recovery, athletic performance, soccer

Brief summary

This study aims to identify the effects of the use of intermittent pneumatic compression on the recovery kinetics following an official soccer match, in comparision with a placebo condition. Participants will perform neuromuscular tests (ie, cmj, low-frequency fatigue), respond to perception scales (RPE, perceived fatigue, soreness, sleep), and biochemical tests (CK analysis). These assessments will be carried out before the match, 30 minutes post match, at the 24th and 48th hour.

Interventions

Following a soccer match, athletes will be enrolled in a recovery treatment: placebo intervention or intermittent pneumatic compression. Participants will be randomly assigned to each group. Neuromuscular tests (cmj) and perceptual questionnaires (hooper index) will be conducted.

Sponsors

University of Maia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 20 Years
Healthy volunteers
Yes

Inclusion criteria

* elite soccer players

Exclusion criteria

* absent from injuries * playing less than 70 minutes

Design outcomes

Primary

MeasureTime frameDescription
Countermovement jump height30 minute, 24 hour, 48 hourHeight measure using CMJ test
low-frequency fatiguebaseline, 30 minute, 24 hour, and 48 hourLFF measured using Myocene (Liege, Belgium)
creatine-kinasebaseline, 24 hour, and 48 hourMuscle damage asses using the biomarker CK
Hooper indexbaseline, 30 minute, 24 hour, and 48 hourApplication of the hooper index questionnaire

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026